Gene-Disorder Association · Article
First reported
1997
Supporting publications
67
Manually curated Approved treatment annotated
Association Review
In brief The association between LEPR (Leptin Receptor) and Body Mass Index Quantitative Trait Locus 11 is well established and manually curated, with its 2 contributing sources — 1 of them expert-curated — recording likely-pathogenic variants.
Sources
2
Clinical variants
4
Symptoms
6
Compounds
1
Trials
18 of 25 via LEPR compounds
Publications
67
Contents
01
At a glance
Association overview A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources 2 sources
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
2 source summaries
A gene summary alongside the source descriptions it was distilled from.
Request access
04
Body Mass Index Quantitative Trait Locus 11
The disorder 13 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
Phenotype
Clinical features 3 clinical features
The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.
Request access
06
ClinVar and variant evidence
Genetic basis 4 clinical variants
ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.
Request access
07
Population genetics
GWAS signals 1 GWAS phenotype
Gene-associated GWAS phenotypes matching the disorder, with best SNP, score, risk-allele frequency and effect size.
Request access
08
Mechanism overlap
Shared mechanisms Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.
Request access
09
Interventions
Therapeutics 1 compound or drug
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
10
Human studies
Clinical trials 25 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
67 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
12
Provenance
References & sources 17 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access